Home > Category > Signaling Pathways > Immunology & Inflammation > CD markers > Anti-Human CD3xCD20 Bispecific Antibody (Mosunetuzumab; BTCT-4465A; R07030816;CD20-TDB; RG7828; CD20 CD3 bispecific antibody.)

Anti-Human CD3xCD20 Bispecific Antibody (Mosunetuzumab; BTCT-4465A; R07030816;CD20-TDB; RG7828; CD20 CD3 bispecific antibody.)

ChemLeader 95+%
Catalog No:CLA1489 CAS No.:1905409-39-3 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity

There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Anti-Human CD3xCD20 Bispecific Antibody (Mosunetuzumab; BTCT-4465A; R07030816;CD20-TDB; RG7828; CD20 CD3 bispecific antibody.)
CAS1905409-39-3
Storage conditionstore at -20°C
Product details

Mosunetuzumab is a humanized bispecific antibody that targets CD20 on B cells and CD3 on T cells, redirecting T-cell cytotoxicity to kill malignant B cells. This IgG1 TDB antibody is being studied for treating relapsed/refractory B-cell non-Hodgkin lymphomas.


Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays